Golimumab (Anti-TNFSF2 / TNFa)

Golimumab (Anti-TNFSF2 / TNFa) is a human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. MW: 146.94 KD.
Supplier Selleck Chemicals
Product # A2892
Sku # A2892-1mg*5
Pricing 1mg*5, $970.00
Feedback